Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1947 1
1950 1
1951 2
1952 5
1953 2
1954 2
1955 1
1956 1
1958 1
1959 2
1960 1
1961 2
1962 2
1963 2
1964 1
1965 2
1966 2
1967 1
1969 1
1971 1
1972 2
1973 1
1974 2
1975 2
1976 1
1977 6
1978 3
1979 1
1980 5
1981 1
1986 1
1988 1
1990 2
1993 2
1994 4
1995 2
1996 2
1997 1
1999 3
2000 6
2001 2
2002 2
2003 5
2004 4
2005 8
2006 12
2007 8
2008 13
2009 19
2010 18
2011 22
2012 30
2013 27
2014 29
2015 21
2016 27
2017 34
2018 18
2019 25
2020 19
2021 19
2022 27
2023 21
2024 24
2025 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

480 results

Results by year

Filters applied: . Clear all
Page 1
Alpha emitter radium-223 and survival in metastatic prostate cancer.
Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, Bottomley D, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Coleman R, Vogelzang NJ, O'Bryan-Tear CG, Staudacher K, Garcia-Vargas J, Shan M, Bruland ØS, Sartor O; ALSYMPCA Investigators. Parker C, et al. N Engl J Med. 2013 Jul 18;369(3):213-23. doi: 10.1056/NEJMoa1213755. N Engl J Med. 2013. PMID: 23863050 Free article. Clinical Trial.
[mHSPC-Therapie mit Apalutamid/ADT].
Bismarck E, Hammerer P, Merseburger AS, Schrader AJ. Bismarck E, et al. Among authors: schrader aj. Oncol Res Treat. 2020;43 Suppl 2:6-12. doi: 10.1159/000507054. Epub 2020 May 20. Oncol Res Treat. 2020. PMID: 32434198 Free article. Review. German. No abstract available.
The dawn of a new era in treating T-PLL.
Schrader A, Braun T, Herling M. Schrader A, et al. Oncotarget. 2019 Jan 18;10(6):626-628. doi: 10.18632/oncotarget.26595. eCollection 2019 Jan 18. Oncotarget. 2019. PMID: 30774758 Free PMC article. No abstract available.
Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia.
Dechow A, Timonen S, Ianevski A, Jiang Q, Wahnschaffe L, Peng Y, Jungherz D, Becker K, Neubauer HA, Schönefeldt S, de Araujo E, Gunning P, Fleck R, Schrader A, Hallek M, Pflug N, Moriggl R, Aittokallio T, Mustjoki S, Braun T, Herling M. Dechow A, et al. Among authors: schrader a. Leukemia. 2025 Jun;39(6):1435-1448. doi: 10.1038/s41375-025-02577-8. Epub 2025 Apr 15. Leukemia. 2025. PMID: 40234614 Free PMC article.
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.
HPS3/TIMI55–REVEAL Collaborative Group; Bowman L, Hopewell JC, Chen F, Wallendszus K, Stevens W, Collins R, Wiviott SD, Cannon CP, Braunwald E, Sammons E, Landray MJ. HPS3/TIMI55–REVEAL Collaborative Group, et al. N Engl J Med. 2017 Sep 28;377(13):1217-1227. doi: 10.1056/NEJMoa1706444. Epub 2017 Aug 28. N Engl J Med. 2017. PMID: 28847206 Free article. Clinical Trial.
Enhancing Biomarker Detection in Cancer: A Comparative Analysis of Preanalytical Reverse Transcription Enzymes for Liquid Biopsy Application.
Wüstmann N, Humberg V, Vieler J, Seitzer K, von Rüden S, Juratli MA, Pascher A, Kemper M, Bleckmann A, Franken A, Neubauer H, Fehm TN, Bögemann M, Schlack K, Schrader AJ, Bernemann C. Wüstmann N, et al. Among authors: schrader aj. Lab Invest. 2024 Oct;104(10):102142. doi: 10.1016/j.labinv.2024.102142. Epub 2024 Sep 20. Lab Invest. 2024. PMID: 39307310 Free article.
cMET: a prognostic marker in papillary renal cell carcinoma?
Erlmeier F, Bruecher B, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Mondorf Y, Ivanyi P, Mikuteit M, Steffens S; German Network Of Kidney Cancer. Erlmeier F, et al. Among authors: schrader aj. Hum Pathol. 2022 Mar;121:1-10. doi: 10.1016/j.humpath.2021.12.007. Epub 2022 Jan 6. Hum Pathol. 2022. PMID: 34998840
Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responses.
von Jan J, Timonen S, Braun T, Jiang Q, Ianevski A, Peng Y, McConnell K, Sindaco P, Müller TA, Pützer S, Klepzig H, Jungherz D, Dechow A, Wahnschaffe L, Giri AK, Kankainen M, Kuusanmäki H, Neubauer HA, Moriggl R, Mazzeo P, Schmidt N, Koch R, Hallek M, Chebel A, Armisen D, Genestier L, Bachy E, Mishra A, Schrader A, Aittokallio T, Mustjoki S, Herling M. von Jan J, et al. Among authors: schrader a. Blood. 2024 Oct 10;144(15):1595-1610. doi: 10.1182/blood.2023022884. Blood. 2024. PMID: 38941598 Free article.
480 results